Ali Alhadab

Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda

Kyle D. Smith, Beatrice Achan, Kathy Huppler Hullsiek et al. · Antimicrobial Agents and Chemotherapy · 2015 · 188 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study

Joshua Rhein, Bożena M Morawski, Kathy Huppler Hullsiek et al. · The Lancet Infectious Diseases · 2016 · 185 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +10

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

Amikacin Pharmacokinetic-Pharmacodynamic Analysis in Pediatric Cancer Patients

Ali Alhadab, Mariam A. Ahmed, Richard C. Brundage · Antimicrobial Agents and Chemotherapy · 2018 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Subcutaneous amivantamab vs intravenous amivantamab, both in combination with lazertinib, in refractory <i>EGFR</i>-mutated, advanced non-small cell lung cancer (NSCLC): Primary results, including overall survival (OS), from the global, phase 3, randomized controlled PALOMA-3 trial.

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 18 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14